Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy

Diabetes - United States
doi 10.2337/db06-1642
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism

mSystems
EvolutionEcologyGeneticsMolecular BiologyBiochemistrySystematicsMicrobiologySimulationComputer Science ApplicationsBehaviorModelingPhysiology
2016English

Protective Effect of Berberine on Renal Fibrosis Caused by Diabetic Nephropathy

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

SRT1720 Retards Renal Fibrosis via Inhibition of HIF1α /GLUT1 in Diabetic Nephropathy

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Antiatherosclerotic Effect of Farnesoid X Receptor

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2009English

Hepatic Carboxylesterase 1 Is Essential for Both Normal and Farnesoid X Receptor-Controlled Lipid Homeostasis

Hepatology
MedicineHepatology
2014English

LncRNA ZEB1-AS1 Was Suppressed by P53 for Renal Fibrosis in Diabetic Nephropathy

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2018English

CDK5 Promotes Renal Tubulointerstitial Fibrosis in Diabetic Nephropathy via ERK1/2/PPARγ Pathway

Oncotarget
Oncology
2016English

LncRNA NR_038323 Suppresses Renal Fibrosis in Diabetic Nephropathy by Targeting miR-324-3p/DUSP1 Axis

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

Farnesoid X Receptor Suppresses Lgr5+ Cancer Stem Cell Proliferation

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy